{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:36:50Z","timestamp":1784860610220,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s40264-021-01053-3","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T14:03:22Z","timestamp":1615212202000},"page":"447-454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Real-World Fetal Exposure to Acne Treatments in the United States: A Retrospective Analysis from 2006 to 2015"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2816-6526","authenticated-orcid":false,"given":"Yasser","family":"Albogami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2790-9938","authenticated-orcid":false,"given":"Amir","family":"Sarayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6945-2713","authenticated-orcid":false,"given":"Juan M.","family":"Hincapie-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6518-5961","authenticated-orcid":false,"given":"Almut G.","family":"Winterstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"1053_CR1","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/ijd.13950","volume":"57","author":"T Kovitwanichkanont","year":"2018","unstructured":"Kovitwanichkanont T, Driscoll T. A comparative review of the isotretinoin pregnancy risk management programs across four continents. Int J Dermatol. 2018;57:1035\u201346. https:\/\/doi.org\/10.1111\/ijd.13950.","journal-title":"Int J Dermatol."},{"key":"1053_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1056\/NEJM198510033131401","volume":"313","author":"EJ Lammer","year":"1985","unstructured":"Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, et al. Retinoic acid embryopathy. N Engl J Med. 1985;313:837\u201341. https:\/\/doi.org\/10.1056\/NEJM198510033131401.","journal-title":"N Engl J Med."},{"key":"1053_CR3","doi-asserted-by":"crossref","unstructured":"Abroms L, Maibach E, Lyon-Daniel K, Feldman SR. What is the best approach to reducing birth defects associated with isotretinoin? PLoS Med. 2006;3. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1637125\/","DOI":"10.1371\/journal.pmed.0030483"},{"key":"1053_CR4","doi-asserted-by":"crossref","unstructured":"Shin J, Cheetham TC, Wong L, Niu F, Kass E, Yoshinaga MA, et al. The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system. J Am Acad Dermatol. 2011;65:1117\u201325. Available from: https:\/\/www.jaad.org\/article\/S0190-9622(10)01101-1\/abstract","DOI":"10.1016\/j.jaad.2010.09.017"},{"key":"1053_CR5","doi-asserted-by":"crossref","unstructured":"Barbieri JS, Frieden IJ, Nagler AR. Isotretinoin, Patient Safety, and Patient-Centered Care\u2014Time to Reform iPLEDGE. JAMA Dermatol [Internet]. American Medical Association; 2020 [cited 2020 Apr 20];156:21\u20132. Available from: https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2753270","DOI":"10.1001\/jamadermatol.2019.3270"},{"key":"1053_CR6","doi-asserted-by":"publisher","unstructured":"Finer LB, Zolna MR. Declines in Unintended Pregnancy in the United States, 2008\u20132011 [Internet]. https:\/\/doi.org\/10.1056\/NEJMsa1506575. Massachusetts Medical Society; 2016 [cited 2020 Apr 20]. Available from: https:\/\/www.nejm.org\/doi\/10.1056\/NEJMsa1506575?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0www.ncbi.nlm.nih.gov","DOI":"10.1056\/NEJMsa1506575"},{"key":"1053_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1684\/ejd.2015.2606","volume":"25","author":"A Ejaz","year":"2015","unstructured":"Ejaz A, Malaiyandi V, Kim WB, Rogalska T, Alhusayen R. Validating the diagnostic code for acne in a tertiary care dermatology centre. Eur J Dermatol EJD. 2015;25:469\u201371.","journal-title":"Eur J Dermatol EJD."},{"key":"1053_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ajmg.c.30313","volume":"157","author":"MP Adam","year":"2011","unstructured":"Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet. 2011;157:175\u201382. https:\/\/doi.org\/10.1002\/ajmg.c.30313.","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"1053_CR9","unstructured":"SOLODYN\u00ae HIGHLIGHTS OF PRESCRIBING INFORMATION [Internet]. [cited 2020 Apr 19]. Available from: https:\/\/accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/050808s014lbl.pdf."},{"key":"1053_CR10","unstructured":"DOXTERIC HIGHLIGHTS OF PRESCRIBING INFORMATION [Internet]. [cited 2020 Apr 19]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/050795Orig1s019lbl.pdf."},{"key":"1053_CR11","unstructured":"MotherToBaby. (2020). The Baby Blog. Retrieved from [Internet]. 2020. Available from: https:\/\/mothertobaby.org\/baby-blog\/."},{"key":"1053_CR12","unstructured":"RISK EVALUATION AND MITIGATION STRATEGY (REMS): The iPLEDGE Program [Internet]. 2012 [cited 2020 Apr 20]. Available from: https:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/UCM234639.pdf."},{"key":"1053_CR13","doi-asserted-by":"crossref","unstructured":"Matcho A, Ryan P, Fife D, Gifkins D, Knoll C, Friedman A. Inferring pregnancy episodes and outcomes within a network of observational databases. PLoS ONE. 2018;13. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5794136\/.","DOI":"10.1371\/journal.pone.0192033"},{"key":"1053_CR14","doi-asserted-by":"publisher","unstructured":"Zhu Y, Hampp C, Wang X, Albogami Y, Wei Y-JJ, Brumback BA, et al. Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract\u2014quantifying the misclassification of maternal drug exposure during pregnancy. Pharmacoepidemiol Drug Saf. 2020;29:1414\u201322. https:\/\/doi.org\/10.1002\/pds.5126.","DOI":"10.1002\/pds.5126"},{"key":"1053_CR15","doi-asserted-by":"crossref","unstructured":"Hornbrook MC, Whitlock EP, Berg CJ, Callaghan WM, Bachman DJ, Gold R, et al. Development of an algorithm to identify pregnancy episodes in an integrated health care delivery system. Health Serv Res [Internet]. 2007 [cited 2020 Apr 20];42:908\u201327. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1955367\/.","DOI":"10.1111\/j.1475-6773.2006.00635.x"},{"key":"1053_CR16","unstructured":"Sarayani A, Albogami Y, Elkhider M, Hincapie-Castillo JM, Brumback BA, Winterstein AG. Comparative effectiveness of risk mitigation strategies to prevent fetal exposure to mycophenolate. BMJ Qual Saf [Internet]. BMJ Publishing Group Ltd; 2019 [cited 2020 Apr 20]; Available from: https:\/\/qualitysafety.bmj.com\/content\/early\/2019\/10\/24\/bmjqs-2019-010098."},{"key":"1053_CR17","unstructured":"DEPO-PROVERA HIGHLIGHTS OF PRESCRIBING INFORMATION [Internet]. [cited 2020 May 6]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/020246s036lbl.pdf."},{"issue":"1151\u20131160","key":"1053_CR18","first-page":"e21","volume":"76","author":"HW Lim","year":"2017","unstructured":"Lim HW, Collins SAB, Resneck JS, Bolognia JL, Hodge JA, Rohrer TA, et al. Contribution of health care factors to the burden of skin disease in the United States. J Am Acad Dermatol. 2017;76(1151\u20131160):e21.","journal-title":"J Am Acad Dermatol."},{"key":"1053_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis."},{"key":"1053_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12888-014-0289-5","volume":"14","author":"KM Fiest","year":"2014","unstructured":"Fiest KM, Jette N, Quan H, St. Germaine-Smith C, Metcalfe A, Patten SB, et al. Systematic review and assessment of validated case definitions for depression in administrative data. BMC Psychiatry. 2014;14:289. https:\/\/doi.org\/10.1186\/s12888-014-0289-5.","journal-title":"BMC Psychiatry."},{"key":"1053_CR21","doi-asserted-by":"publisher","first-page":"676.e1","DOI":"10.1016\/j.ajog.2017.08.006","volume":"217","author":"LB Haddad","year":"2017","unstructured":"Haddad LB, Monsour M, Tepper NK, Whiteman MK, Kourtis AP, Jamieson DJ. Trends in contraceptive use according to HIV status among privately insured women in the United States. Am J Obstet Gynecol. 2017;217:676.e1-676.e11.","journal-title":"Am J Obstet Gynecol."},{"key":"1053_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.whi.2018.01.005","volume":"28","author":"AH Snyder","year":"2018","unstructured":"Snyder AH, Weisman CS, Liu G, Leslie D, Chuang CH. The impact of the affordable care act on contraceptive use and costs among privately insured women. Womens Health Issues Off Publ Jacobs Inst Womens Health. 2018;28:219\u201323.","journal-title":"Womens Health Issues Off Publ Jacobs Inst Womens Health."},{"key":"1053_CR23","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34:3661\u201379.","journal-title":"Stat Med."},{"key":"1053_CR24","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis [Internet]. Springer-Verlag New York; 2016 [cited 2020 Apr 20]. Available from: https:\/\/ggplot2.tidyverse.org."},{"key":"1053_CR25","unstructured":"National Vital Statistics Reports, Volume 66, Number 1, January 5, 2017. p. 70."},{"key":"1053_CR26","doi-asserted-by":"crossref","unstructured":"Choi JS, Koren G, Nulman I. Pregnancy and isotretinoin therapy. CMAJ Can Med Assoc J [Internet]. 2013 [cited 2020 Apr 22];185:411\u20133. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3602257\/.","DOI":"10.1503\/cmaj.120729"},{"key":"1053_CR27","doi-asserted-by":"crossref","unstructured":"Collins M-K, Moreau JF, Opel D, Swan J, Prevost N, Hastings M, et al. Compliance with pregnancy prevention measures during isotretinoin therapy. J Am Acad Dermatol [Internet]. 2014 [cited 2020 Apr 22];70:55\u20139. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0190962213009092.","DOI":"10.1016\/j.jaad.2013.08.034"},{"key":"1053_CR28","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/pds.3481","volume":"22","author":"SP Pinheiro","year":"2013","unstructured":"Pinheiro SP, Kang EM, Kim CY, Governale LA, Zhou EH, Hammad TA. Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States. Pharmacoepidemiol Drug Saf. 2013;22:1251\u20137. https:\/\/doi.org\/10.1002\/pds.3481.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"1053_CR29","doi-asserted-by":"publisher","unstructured":"Crijns HJMJ, Rein N van, Wied CCG, Straus SM, Berg LTW de J den. Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non-users: a drug utilisation study. Pharmacoepidemiol Drug Saf. 2012;21:1060\u20136. https:\/\/doi.org\/10.1002\/pds.3200.","DOI":"10.1002\/pds.3200"},{"key":"1053_CR30","doi-asserted-by":"crossref","unstructured":"Henry D, Dormuth C, Winquist B, Carney G, Bugden S, Teare G, et al. Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy. CMAJ Can Med Assoc J [Internet]. 2016 [cited 2020 Apr 22];188:723\u201330. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4938682\/.","DOI":"10.1503\/cmaj.151243"},{"key":"1053_CR31","doi-asserted-by":"crossref","unstructured":"Uusk\u00fcla A, Pisarev H, Kurvits K, Laius O, Laanpere M, Uusk\u00fcla M. Compliance with Pregnancy Prevention Recommendations for Isotretinoin in Estonia in 2012\u20132016. Drugs - Real World Outcomes [Internet]. 2018 [cited 2020 Apr 22];5:129\u201336. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5984611\/.","DOI":"10.1007\/s40801-018-0135-z"},{"key":"1053_CR32","unstructured":"Daniels K, Dougherty J, Jones J. Current contraceptive status among women aged 15-44: United States, 2011\u20132013. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2014."},{"key":"1053_CR33","first-page":"1","volume":"2012","author":"J Jones","year":"1995","unstructured":"Jones J, Mosher W, Daniels K. Current contraceptive use in the United States, 2006\u20132010, and changes in patterns of use since. Natl Health Stat Rep. 1995;2012:1\u201325.","journal-title":"Natl Health Stat Rep."},{"key":"1053_CR34","doi-asserted-by":"crossref","unstructured":"Trussell J. Contraceptive failure in the United States. Contraception [Internet]. 2011 [cited 2020 Apr 22];83:397\u2013404. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3638209\/.","DOI":"10.1016\/j.contraception.2011.01.021"},{"key":"1053_CR35","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","volume":"366","author":"B Winner","year":"2012","unstructured":"Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366:1998\u20132007. https:\/\/doi.org\/10.1056\/NEJMoa1110855.","journal-title":"N Engl J Med."},{"key":"1053_CR36","doi-asserted-by":"crossref","unstructured":"Marks A, Malizio J, Hoch J, Brody R, Fisher M. Assessment of health needs and willingness to utilize health care resources of adolescents in a suburban population. J Pediatr [Internet]. 1983 [cited 2020 Apr 22];102:456\u201360. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022347683806775.","DOI":"10.1016\/S0022-3476(83)80677-5"},{"key":"1053_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1023\/A:1021158016268","volume":"6","author":"C Cubbin","year":"2002","unstructured":"Cubbin C, Braveman PA, Marchi KS, Chavez GF, Santelli JS, Gilbert BJC. Socioeconomic and racial\/ethnic disparities in unintended pregnancy among postpartum women in California. Matern Child Health J. 2002;6:237\u201346.","journal-title":"Matern Child Health J."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-021-01053-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-021-01053-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-021-01053-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T23:25:34Z","timestamp":1616714734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-021-01053-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1053"],"URL":"https:\/\/doi.org\/10.1007\/s40264-021-01053-3","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,8]]},"assertion":[{"value":"3 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Yasser Albogami, Amir Sarayani, Juan Hincapie-Castillo, and Almut G. Winterstein have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was exempted from approval by the Institutional Review Board at the University of Florida because deidentified data were used.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors read the final version of the manuscript and gave consent for publication.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data may be obtained from a third party and are not publicly available.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Available upon request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors were involved in the conception and design, interpretation of data, drafting the manuscript or revising it critically for important intellectual content.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}